We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
-11.37%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$890M
AUM Growth
-$297M
Cap. Flow
-$242M
Cap. Flow %
-27.15%
Top 10 Hldgs %
37.94%
Holding
102
New
32
Increased
15
Reduced
23
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 33.24%
2 Technology 27.74%
3 Consumer Discretionary 8.7%
4 Communication Services 5.66%
5 Industrials 4.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRNC icon
51
PUT
Cerence
CRNC
$405M
$5.05M 0.57%
+2,000
New +$59.8K
CYTK icon
52
Cytokinetics
CYTK
$10.4B
$4.99M 0.56%
+127,010
New +$5.11M
APLS
53
DELISTED
Apellis Pharmaceuticals
APLS
$4.97M 0.56%
+110,000
New +$5.02M
ALT icon
54
Altimmune
ALT
$595M
$4.81M 0.54%
+411,039
New +$2.53M
AAN
55
PUT
DELISTED
The Aaron's Company Inc
AAN
$4.44M 0.5%
+3,052
New +$58.2K
GH icon
56
CALL
Guardant Health
GH
$22.2B
$4.03M 0.45%
+1,000
New +$49.5K
AXSM icon
57
CALL
Axsome Therapeutics
AXSM
$10.8B
$3.83M 0.43%
+1,000
New +$31.6K
PLL
58
PUT
DELISTED
Piedmont Lithium
PLL
$3.64M 0.41%
+1,000
New +$59.2K
CORT icon
59
PUT
Corcept Therapeutics
CORT
$11.8B
$3.57M 0.4%
1,500
ZIP icon
60
PUT
ZipRecruiter
ZIP
$418M
$3.56M 0.4%
+2,400
New +$47.6K
FCX icon
61
Freeport-McMoran
FCX
$96.9B
$3.51M 0.39%
120,000
-410,000
-77% -$16.4M
BWXT icon
62
BWX Technologies
BWXT
$15.6B
$3.2M 0.36%
+58,000
New +$3.02M
SNBR
63
PUT
DELISTED
Sleep Number
SNBR
$3.09M 0.35%
+1,000
New +$42.5K
GMED icon
64
PUT
Globus Medical
GMED
$11.2B
$2.81M 0.32%
+500
New +$32.9K
ABNB icon
65
Airbnb
ABNB
$103B
$2.67M 0.3%
30,000
-109,000
-78% -$14.2M
NTLA icon
66
CALL
Intellia Therapeutics
NTLA
$1.63B
$2.59M 0.29%
+500
New +$25.4K
GFS icon
67
PUT
GlobalFoundries
GFS
$28.5B
$2.19M 0.25%
+542
New +$28.6K
KRYS icon
68
Krystal Biotech
KRYS
$9.51B
$1.97M 0.22%
+30,000
New +$1.87M
WAVC.U
69
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
$1.94M 0.22%
200,000
PRCT icon
70
Procept Biorobotics
PRCT
$1.17B
$1.9M 0.21%
58,138
CHWY icon
71
CALL
Chewy
CHWY
$9.76B
$1.74M 0.2%
+500
New +$16K
INMD icon
72
PUT
InMode
INMD
$875M
$1.34M 0.15%
+600
New +$15.8K
NTLA icon
73
Intellia Therapeutics
NTLA
$1.63B
$1.22M 0.14%
23,500
-6,500
-22% -$330K
DJT icon
74
PUT
Trump Media & Technology Group
DJT
$2.79B
$1.21M 0.14%
+500
New +$20.9K
TAST
75
DELISTED
Carrols Restaurant Group, Inc.
TAST
$1.13M 0.13%
+561,108
New +$1.05M

Similar funds

Atika Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Atika Capital Management held 102 positions worth $890M, down 25% from $1.19B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Atika Capital Management withdrew a net $242M in Q2 2022, closing 26 positions and reducing 23 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $31.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Atika Capital Management opened a new position in Seagen Inc. Common Stock worth $50M.

  • Atika Capital Management's largest Q2 2022 buy was Seagen Inc. Common Stock: 282,500 shares worth $50M.
  • Atika Capital Management added most to Liberty Media Series C in Q2 2022, an estimated $18.6M increase.
  • Atika Capital Management's biggest Q2 2022 reduction was Palo Alto Networks, cutting an estimated $19.4M.
  • Atika Capital Management fully exited Alphabet (Google) Class C in Q2 2022, selling an estimated $31.3M.
  • Atika Capital Management's ten largest holdings make up 38% of its $890M portfolio in Q2 2022.
  • Atika Capital Management opened 32 new positions and closed 26 in Q2 2022.
  • Atika Capital Management's portfolio value fell 25% quarter-over-quarter to $890M.

Based on Atika Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.